NL-OMON26233Other不适用
Clinical evaluation of a prototype drop-in gamma probe for (robot-assisted) laparoscopic sentinel node biopsy
KI-AV0 个研究点目标入组 25 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- Other
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •-Patients > 18 years of age;
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •-Patients with a history of iodine allergy;
研究者
相似试验
尚未招募
不适用
Clinical evaluation of a prototype drop-in probe for (robot-assisted) laparoscopic sentinel node biopsy<br>NL-OMON45762ederlands Kanker Instituut25
已完成
不适用
Clinical Study of the GEM Combined Use Gamma Delta T Immune-Cells Treatment an Excision Impossible Paccreatic CancerPancreatic CancerJPRN-UMIN000013794Tomishiro Central Hospital11
进行中（未招募）
1 期
ivolumab and ipilimumab in combination for lung cancer.on-Small Cell Lung CancerMedDRA version: 21.0Level: LLTClassification code 10048683Term: Advanced cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-002621-10-BEBristol-Myers Squibb International Corporation2,240
已完成
3 期
A Phase IIIb/IV Safety Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung CancerNon-small cell lung cancerNL-OMON47686Bristol-Myers Squibb22
进行中（未招募）
1 期
ivolumab and ipilimumab in combination for advanced malignancies.Advanced MalignanciesMedDRA version: 19.0Level: LLTClassification code 10048683Term: Advanced cancerSystem Organ Class: 100000004864EUCTR2016-002621-10-FRBristol-Myers Squibb International Corporation500